Vertex’s Trikafta pricing central to cystic fibrosis treatment disparities, study says fkansteiner Mon, 02/14/2022 – 11:59 More: Vertex's Trikafta pricing central to cystic fibrosis treatment disparities, study says Source: fierce
read morePfizer and Regeneron led pharma’s sales growth in Q4 while Teva, Biogen and Gilead lagged kdunleavy Mon, 02/14/2022 – 11:43 More: Pfizer and Regeneron led pharma's sales growth in Q4 while Teva, Biogen and Gilead lagged Source: fierce
read moreNovartis plots 400 job cuts in India after striking sales pact with Dr. Reddy’s fkansteiner Mon, 02/14/2022 – 10:30 More: Novartis plots 400 job cuts in India after striking sales pact with Dr. Reddy's Source: fierce
read moreAstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M fkansteiner Mon, 02/14/2022 – 09:47 More: AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to 5M Source: fierce
read moreModerna eyes UK for next leg of mRNA vaccine manufacturing journey: report fkansteiner Mon, 02/14/2022 – 08:59 More: Moderna eyes UK for next leg of mRNA vaccine manufacturing journey: report Source: fierce
read moreHeart conditions among women in Wales are not being diagnosed due to systemic failures More: Women in Wales at higher risk of heart disease misdiagnosis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals